The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Jentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545 · cited 3×
“…measures, we observed a greater effect of nicotine in individuals with schizophrenia compared with controls on aspects of attentional function that may be mediated via an improvement in response inhibition, which refers to the ability to suppress inappropriate responses (Jentsch and Taylor, 1999).”
BackgroundCognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · cited 1×
“…to polymorphisms at the site of the a7nAChR gene on chromosome 15q14 and is transiently reversed by nicotine administration in smokers with schizophrenia and in nonsmoking first-degree relatives of patients with schizophrenia (Adler et al, 1992, 1993; Freedman et al, 1997; Leonard et al, 2002).”
BackgroundDopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070 · cited 1×
“There is increasing evidence that nAChR stimulation has beneficial effects on cognitive function in schizophrenia, possibly via presynaptic modulation of dopamine and/or glutamate release (McGehee et al, 1995; George et al, 2000; Picciotto et al, 2000; Wonnacott et al, 2000).”
BackgroundPrevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · cited 2×
“…combined with the observation that the prevalence of cigarette smoking is much higher in schizophrenia compared with the general population, (Hughes, 1986; de Leon et al, 2002) have led to the hypothesis that smoking represents a form of self-medication for patients with psychiatric…”
BackgroundCornblatt, B. A., Risch, N. J., Faris, G., Friedman, D., & Erlenmeyer-Kimling, L. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90076-5 · Cited by 682
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Aron, A. R., & Poldrack, R. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.026 · Cited by 602
Bupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509
Nicotine effects on adults with attention-deficit/hyperactivity disorder
Levin, E. D., Conners, C. K., Sparrow, E., Hinton, S. C., Erhardt, D., Meck, W. H., Rose, J. E., & March, J. (1996) · Psychopharmacology · doi:10.1007/bf02246281 · Cited by 415
An interactive framework for examining prefrontal cognitive processes
Roberts, R. J., & Pennington, B. F. (1996) · Developmental Neuropsychology · doi:10.1080/87565649609540642 · Cited by 392
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354 · cited 1×
“There is increasing evidence that nAChR stimulation has beneficial effects on cognitive function in schizophrenia, possibly via presynaptic modulation of dopamine and/or glutamate release (McGehee et al, 1995; George et al, 2000; Picciotto et al, 2000; Wonnacott et al, 2000).”
BackgroundPresynaptic nicotinic receptors modulating dopamine release in the rat striatum
Wonnacott, S., Kaiser, S., Mogg, A., Soliakov, L., & Jones, I. W. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00005-4 · Cited by 232 · cited 1×
“There is increasing evidence that nAChR stimulation has beneficial effects on cognitive function in schizophrenia, possibly via presynaptic modulation of dopamine and/or glutamate release (McGehee et al, 1995; George et al, 2000; Picciotto et al, 2000; Wonnacott et al, 2000).”
BackgroundMehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051102 · Cited by 223 · cited 1×
“The dopaminergic system is believed to modulate a range of cognitive processes, including response inhibition (Brozoski et al, 1979; Mehta et al, 1999; Cropley et al, 2006).”
BackgroundDawkins, L., Powell, J. H., West, R., Powell, J., & Pickering, A. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0634-6 · Cited by 85 · cited 1×
“Furthermore, in a recent study in smokers without psychiatric disorder, smoking abstinence resulted in impairments in response inhibition that were reversed by nicotine administration (Dawkins et al, 2007).”
Background(1993) · doi:10.1016/0376-8716(93)90041-n · Cited by 77
Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices
Hennings, E. C. P., Kiss, J. P., & Vizi, E. S. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00343-0 · Cited by 55 · cited 1×
“Seven participants were treated with either bupropion or fluoxetine, which have been shown to have nicotinic antagonist properties in vitro (Hennings et al, 1997; Slemmer et al, 2000).”
Background
Cited by
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
“In controlled experiments on schizophrenia patients, nicotine has been found to enhance cognitive function [121–123].”
BackgroundInitial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426
Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
“There is also evidence in people with schizophrenia that nicotine has greater effects on some aspects of cognitive performance (Barr et al., 2008), and that there is abnormal regulation of high affinity nicotinic receptors compared to healthy people (Breese et al.”
BackgroundCognitive function during nicotine withdrawal: Implications for nicotine dependence treatment
Ashare, R. L., Falcone, M., & Lerman, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.034 · Cited by 170
Metadata
- Authors
- Barr, R. S., Culhane, M. A., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P., Deckersbach, T., Kelly, J. F., Freudenreich, O., Goff, D. C., & Evins, A. E.
- Venue
- Neuropsychopharmacology
- Published
- 2007-04-18
- Volume
- 33
- Issue
- 3
- Pages
- 480-490
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1965198880
- Cited by
- 238
- References
- 20
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.